tag glp-1 
Fuld & Company Blog
MARCH 27, 2023
The background of semaglutide Nearly 20 years ago the first glucagon-like peptide 1 (GLP-1), a class of Type 2 diabetes drug that improves blood sugar, was launched, creating what is today a market worth nearly $30B. The approval was soon followed by multiple other GLP-1 launches, creating a hugely successful class of drugs.
Pharmaceutical Technology
NOVEMBER 30, 2022
Mounjaro is a combination of the two gut hormones GLP-1 and GIP. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. weight loss in obese or overweight individuals. compared to a 5.1%
Pharmaceutical Technology
NOVEMBER 30, 2022
Mounjaro is a combination of the two gut hormones GLP-1 and GIP. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3. weight loss in obese or overweight individuals. compared to a 5.1%
Expert insights. Personalized for you.
52 
Let's personalize your content